Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Cytarabine 35 Cyclophosphamide 26 Etoposide 18 Radiotherapy 16 Daunorubicin 16 Busulfan 15 Peripheral Blood Stem Cell Transplantation 14 Methotrexate 14 Idarubicin 14 Mercaptopurine 12 Dexamethasone 12 Vincristine 11 Thioguanine 9 Mitoxantrone 9 Doxorubicin 8 Asparaginase 8 Antilymphocyte Serum 8 pegaspargase 7 fludarabine phosphate 7 Prednisolone 7 Polymerase Chain Reaction 7 Filgrastim 7 Cyclosporine 7 Prednisone 6 Mycophenolic Acid 5 Melphalan 5 Leucovorin 5 Gene Expression Profiling 5 Vindesine 4 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia × Antibodies, Monoclonal × Clear all

NCT00515892 2007-08-14

NHL

Cambridge Antibody Technology

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡